Effects of sulfasalazine in axial spondyloarthritis on COVID-19 outcomes: real-life data from a single center-Reference-Cited by-同舟云学术

Effects of sulfasalazine in axial spondyloarthritis on COVID-19 outcomes: real-life data from a single center

Published:2022-12-28 Issue: Volume: Page:1-7
ISSN:0892-3973
Container-title:Immunopharmacology and Immunotoxicology
language:en
Short-container-title:Immunopharmacology and Immunotoxicology

Author:

Armağan Berkan¹^ORCID,Atalar Ebru¹,Güven Serdar Can¹^ORCID,Özdemir Bahar¹,Konak Hatice Ecem¹,Akyüz Dağlı Pınar¹,Erden Abdulsamet¹^ORCID,Gök Kevser¹,Maraş Yüksel²,Doğan İsmail³,Küçükşahin Orhan³^ORCID,Erten Şükran³,Omma Ahmet¹^ORCID

Affiliation:

1. Rheumatology Clinic, Ankara City Hospital, Ankara, Turkey

2. Division of Rheumatology, Ankara City Hospital, University of Health Sciences, Ankara, Turkey

3. Division of Rheumatology, Department of Internal Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turkey

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/08923973.2022.2160729

Reference31 articles.

1. Escaping Pandora’s Box — Another Novel Coronavirus

2. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

3. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

4. Cytokine Storm

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic study on the improvement of immune inflammation in ankylosing spondylitis through regulation of the PI3K/AKT signaling pathway by Huangqin Qingre Chubi capsules;International Journal of Rheumatic Diseases;2024-06

2. The impact of the COVID-19 pandemic on pediatric rheumatology practice: an international, cross-sectional survey study;Seminars in Arthritis and Rheumatism;2023-12

3. The outcome of COVID‐19 in patients with autoimmune rheumatic diseases: Comparable to the general population or worse?;International Journal of Rheumatic Diseases;2023-08